TransEnterix, Inc.

TransEnterix, Inc. price (TRXC)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About TransEnterix, Inc.

TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

Sector
Commercial Services
CEO
Todd M. Pope
Industry
Commercial Services
Exchange
ASE

Top Stories

Coming soon.